Leticia Espinoza Alfaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Leticia Espinoza Alfaro has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Paola Ortiz Valdés
Hospital de Alta Especialidad Bicentenario de la Independencia ISSSTE
4 shared publications - Karla Leslie Martínez Hernández
Universidad Anáhuac México
2 shared publications - Marianella Insandará Paz
Avances en Estrategias Basadas en Imágenes para la Detección Temprana del Melanoma Amelanótico Validación Clínica y Perspectivas Internacionales Hospital de Alta Especialidad Quality Consulting /ieccmexico.com/publishing un artículo de acceso abierto distribuido Bicentenario de la Independencia Pontificia Universidad Javeriana Cali EPS Sanitas Universidad Anáhuac México Pontificia Universidad Javeriana Instituto de Educación Capacitación y Certificación de México. https
2 shared publications - María Angélica Mosquera Romero
Universidad Santiago de Cali
2 shared publications - Andres Felipe Herrera Homez
Avances en Estrategias Basadas en Imágenes para la Detección Temprana del Melanoma Amelanótico Validación Clínica y Perspectivas Internacionales Hospital de Alta Especialidad Quality Consulting /ieccmexico.com/publishing un artículo de acceso abierto distribuido Bicentenario de la Independencia Pontificia Universidad Javeriana Cali EPS Sanitas Universidad Anáhuac México Pontificia Universidad Javeriana Instituto de Educación Capacitación y Certificación de México. https
1 shared publication - Andres Felipe Quimbayo Cifuentes
/ieccmexico.com/publishing un artículo de acceso abierto distribuido Universidad Autónoma de Chiapas Centros Medicos Colsanitas SAS Universidad Peruana de Ciencias Aplicadas Universidad del Sinú Tecnológico de Monterrey Universidad de Santander Consulting Instituto de Educación Capacitación y Certificación de México. https particularmente México Colombia y Ecuador
1 shared publication
Latest Publications
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Advances in Image-Based Strategies for the Early Detection of Amelanotic Melanoma: Clinical Validation and International Perspectives
Amelanotic melanoma represents a diagnostically challenging subtype of melanoma due to the absence or minimal presence of pigmentation, which often leads to delayed recognition and poorer clinical outcomes. Early detection is therefore critical, yet traditional visual and dermoscopic criteria demonstrate limited sensitivity for non-pigmented lesions. In recent years, advanced image-based diagnostic approaches have shown promising performance in melanoma detection; however, their applicability to amelanotic melanoma and their validation across diverse clinical contexts remain insufficiently explored. This review analyzes current evidence on image-based strategies for the early detection of amelanotic melanoma, focusing on diagnostic performance, clinical validation, and integration into real-world practice. A structured narrative review methodology was employed, synthesizing findings from comparative performance studies, clinical validation trials, benchmarking initiatives, and meta-analyses. The results indicate that while image-based approaches can enhance diagnostic sensitivity and support clinician decision-making, their effectiveness is strongly influenced by dataset representation, lesion subtype complexity, and clinician–system interaction. Evidence further supports the value of multimodal diagnostic pathways that integrate clinical evaluation, dermoscopy, image-based analysis, and adjunctive imaging in diagnostically ambiguous cases.
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Advances in Image-Based Strategies for the Early Detection of Amelanotic Melanoma: Clinical Validation and International Perspectives
Amelanotic melanoma represents a diagnostically challenging subtype of melanoma due to the absence or minimal presence of pigmentation, which often leads to delayed recognition and poorer clinical outcomes. Early detection is therefore critical, yet traditional visual and dermoscopic criteria demonstrate limited sensitivity for non-pigmented lesions. In recent years, advanced image-based diagnostic approaches have shown promising performance in melanoma detection; however, their applicability to amelanotic melanoma and their validation across diverse clinical contexts remain insufficiently explored. This review analyzes current evidence on image-based strategies for the early detection of amelanotic melanoma, focusing on diagnostic performance, clinical validation, and integration into real-world practice. A structured narrative review methodology was employed, synthesizing findings from comparative performance studies, clinical validation trials, benchmarking initiatives, and meta-analyses. The results indicate that while image-based approaches can enhance diagnostic sensitivity and support clinician decision-making, their effectiveness is strongly influenced by dataset representation, lesion subtype complexity, and clinician–system interaction. Evidence further supports the value of multimodal diagnostic pathways that integrate clinical evaluation, dermoscopy, image-based analysis, and adjunctive imaging in diagnostically ambiguous cases.
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Early Metabolic Vulnerability and Frailty-Related Pathways in Young Adults
Metabolic frailty has traditionally been associated with older populations; however, accumulating evidence suggests that frailty-related metabolic alterations may emerge much earlier in the life course. This narrative review examines metabolic frailty in young adults as an early vulnerability state characterized by metabolic dysregulation, adverse body composition, chronic low-grade inflammation, and reduced physiological reserve, even in the absence of overt chronic disease. Drawing on international literature and integrating evidence relevant to Latin American contexts, particularly Mexico, Colombia, and Ecuador, this study synthesizes current knowledge on the biological and clinical pathways linking central adiposity, insulin resistance, sarcopenia-related changes, and cardiometabolic risk clustering to early frailty-related processes. The findings support the interpretation of metabolic frailty as a continuous, multidimensional construct that extends classical frailty frameworks beyond geriatric populations. Early identification of metabolic frailty using combined anthropometric, metabolic, and muscle-related indicators may provide a valuable opportunity to prevent or delay the onset of chronic noncommunicable diseases and preserve long-term functional capacity.
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Early Metabolic Vulnerability and Frailty-Related Pathways in Young Adults
Metabolic frailty has traditionally been associated with older populations; however, accumulating evidence suggests that frailty-related metabolic alterations may emerge much earlier in the life course. This narrative review examines metabolic frailty in young adults as an early vulnerability state characterized by metabolic dysregulation, adverse body composition, chronic low-grade inflammation, and reduced physiological reserve, even in the absence of overt chronic disease. Drawing on international literature and integrating evidence relevant to Latin American contexts, particularly Mexico, Colombia, and Ecuador, this study synthesizes current knowledge on the biological and clinical pathways linking central adiposity, insulin resistance, sarcopenia-related changes, and cardiometabolic risk clustering to early frailty-related processes. The findings support the interpretation of metabolic frailty as a continuous, multidimensional construct that extends classical frailty frameworks beyond geriatric populations. Early identification of metabolic frailty using combined anthropometric, metabolic, and muscle-related indicators may provide a valuable opportunity to prevent or delay the onset of chronic noncommunicable diseases and preserve long-term functional capacity.
- 10 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Interconnected Pathways of Metabolic Decline: A Triad Model Linking Inflammasome Activation, Microbiota Dysbiosis, and Cellular Aging
Metabolic diseases constitute a growing global health burden and increasingly demand integrative biological frameworks that transcend organ-specific perspectives. This review synthesizes evidence demonstrating that metabolic deterioration arises from the interaction of three interconnected mechanisms: NLRP3 inflammasome activation, gut microbiota dysbiosis, and cellular aging/senescence. Using a structured scientific methodology, we examined mechanistic, translational, and clinical research across immunology, microbiology, and geroscience. The results highlight that inflammasome activity exerts systemic metabolic effects, influencing insulin resistance, liver injury, vascular remodeling, and renal dysfunction. In parallel, microbiota alterations follow a graded pattern that mirrors disease severity, aging trajectories, and immune dysregulation. Cellular senescence emerges as both a consequence and amplifier of metabolic stress, contributing to chronic inflammation and multi-organ vulnerability through SASP-mediated signaling. When integrated, these mechanisms form a self-reinforcing pathogenic triad that offers a more accurate explanation for the multisystemic nature and progression of metabolic disease. The model presented underscores the need for multidimensional therapeutic strategies that target inflammation, microbial ecology, and aging biology simultaneously. This triad-based framework is particularly relevant for regions undergoing rapid epidemiologic transitions, including Mexico, Colombia, and Ecuador, where metabolic disorders continue to rise.
- 10 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Interconnected Pathways of Metabolic Decline: A Triad Model Linking Inflammasome Activation, Microbiota Dysbiosis, and Cellular Aging
Metabolic diseases constitute a growing global health burden and increasingly demand integrative biological frameworks that transcend organ-specific perspectives. This review synthesizes evidence demonstrating that metabolic deterioration arises from the interaction of three interconnected mechanisms: NLRP3 inflammasome activation, gut microbiota dysbiosis, and cellular aging/senescence. Using a structured scientific methodology, we examined mechanistic, translational, and clinical research across immunology, microbiology, and geroscience. The results highlight that inflammasome activity exerts systemic metabolic effects, influencing insulin resistance, liver injury, vascular remodeling, and renal dysfunction. In parallel, microbiota alterations follow a graded pattern that mirrors disease severity, aging trajectories, and immune dysregulation. Cellular senescence emerges as both a consequence and amplifier of metabolic stress, contributing to chronic inflammation and multi-organ vulnerability through SASP-mediated signaling. When integrated, these mechanisms form a self-reinforcing pathogenic triad that offers a more accurate explanation for the multisystemic nature and progression of metabolic disease. The model presented underscores the need for multidimensional therapeutic strategies that target inflammation, microbial ecology, and aging biology simultaneously. This triad-based framework is particularly relevant for regions undergoing rapid epidemiologic transitions, including Mexico, Colombia, and Ecuador, where metabolic disorders continue to rise.
- Open Access
- 26 November 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Next-Generation Skin Regeneration: Multicellular 3D Bioprinting and Biomimetic Bioinks for Advanced Cutaneous Reconstruction
Regenerative dermatology and 3D skin bioprinting have advanced rapidly over the past decade, offering new possibilities for restoring complex cutaneous architecture beyond the limitations of traditional grafting techniques. This review synthesizes evidence from twenty recent studies to evaluate technological innovations, biological strategies, and translational progress in the fabrication of functional human skin. The findings indicate a clear predominance of extrusion-based platforms, supported by emerging microfluidic, hybrid, and in situ systems that enhance structural fidelity and dynamic responsiveness. Bioinks have evolved from simple hydrogels to biologically instructive matrices, including GelMA-based formulations, alginate–gelatin composites, ECM-derived hydrogels, placental matrices, and peptide-functionalized biomaterials. These materials not only support high cell viability but also modulate angiogenesis, immune responses, and extracellular matrix organization. Multicellular strategies incorporating keratinocytes, fibroblasts, endothelial cells, pericytes, and stem cells demonstrate superior performance in vascular integration, tissue maturation, and appendage regeneration. Vascularization remains the critical determinant of clinical viability, with endothelial co-printing, sacrificial-channel scaffolds, and angiogenic bioinks emerging as complementary approaches to overcome diffusion limitations. Current applications are concentrated in wound healing, where bioprinted constructs improve closure and integration, and in disease modeling, where they enable physiologically relevant platforms for pharmacologic testing. In situ bioprinting represents a developing frontier for personalized bedside reconstruction. Collectively, the evidence shows that 3D bioprinting is transitioning toward translational readiness, supported by interdisciplinary advances and growing international participation, including key contributions from Mexico, Colombia, and Ecuador. Continued progress depends on refining vascular strategies, standardizing bioinks, and expanding collaborative research to ensure equitable future clinical implementation.
- 26 November 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Open AccessNext-Generation Skin Regeneration: Multicellular 3D Bioprinting and Biomimetic Bioinks for Advanced Cutaneous Reconstruction
Regenerative dermatology and 3D skin bioprinting have advanced rapidly over the past decade, offering new possibilities for restoring complex cutaneous architecture beyond the limitations of traditional grafting techniques. This review synthesizes evidence from twenty recent studies to evaluate technological innovations, biological strategies, and translational progress in the fabrication of functional human skin. The findings indicate a clear predominance of extrusion-based platforms, supported by emerging microfluidic, hybrid, and in situ systems that enhance structural fidelity and dynamic responsiveness. Bioinks have evolved from simple hydrogels to biologically instructive matrices, including GelMA-based formulations, alginate–gelatin composites, ECM-derived hydrogels, placental matrices, and peptide-functionalized biomaterials. These materials not only support high cell viability but also modulate angiogenesis, immune responses, and extracellular matrix organization. Multicellular strategies incorporating keratinocytes, fibroblasts, endothelial cells, pericytes, and stem cells demonstrate superior performance in vascular integration, tissue maturation, and appendage regeneration. Vascularization remains the critical determinant of clinical viability, with endothelial co-printing, sacrificial-channel scaffolds, and angiogenic bioinks emerging as complementary approaches to overcome diffusion limitations. Current applications are concentrated in wound healing, where bioprinted constructs improve closure and integration, and in disease modeling, where they enable physiologically relevant platforms for pharmacologic testing. In situ bioprinting represents a developing frontier for personalized bedside reconstruction. Collectively, the evidence shows that 3D bioprinting is transitioning toward translational readiness, supported by interdisciplinary advances and growing international participation, including key contributions from Mexico, Colombia, and Ecuador. Continued progress depends on refining vascular strategies, standardizing bioinks, and expanding collaborative research to ensure equitable future clinical implementation.
- 8 October 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 2 (2)
Chronic Inflammatory Dermatoses and Metabolic Dysregulation: Evidence for a Systemic Disease Model
Chronic inflammatory skin diseases have increasingly been recognized as systemic disorders with clinically significant extracutaneous manifestations. Among these, the association between chronic cutaneous inflammation and metabolic syndrome has emerged as a relevant and reproducible pattern across epidemiological, clinical, and mechanistic studies. This review synthesizes current evidence examining the bidirectional relationship between chronic inflammatory dermatoses—primarily psoriasis and moderate-to-severe atopic dermatitis—and metabolic syndrome, including its key components: obesity, insulin resistance, dyslipidemia, hypertension, and type 2 diabetes mellitus. Population-based studies and meta-analyses consistently demonstrate a higher prevalence of metabolic syndrome and related metabolic abnormalities in patients with chronic inflammatory skin disease, with stronger associations observed in more severe disease phenotypes. Mechanistic data support these observations, highlighting shared inflammatory pathways, cytokine signaling, adipokine imbalance, and immunometabolic interactions as common underlying processes. The findings discussed in this review reinforce the concept of systemic inflammation as a unifying framework linking skin and metabolic disease. Recognizing chronic inflammatory dermatoses as markers of increased metabolic risk has important implications for clinical practice, preventive strategies, and medical education. An integrated, multidisciplinary approach may facilitate earlier identification of cardiometabolic risk and improve long-term outcomes, particularly in regions experiencing a rising burden of metabolic disease, such as Latin America.
- 8 October 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 2 (2)
Chronic Inflammatory Dermatoses and Metabolic Dysregulation: Evidence for a Systemic Disease Model
Chronic inflammatory skin diseases have increasingly been recognized as systemic disorders with clinically significant extracutaneous manifestations. Among these, the association between chronic cutaneous inflammation and metabolic syndrome has emerged as a relevant and reproducible pattern across epidemiological, clinical, and mechanistic studies. This review synthesizes current evidence examining the bidirectional relationship between chronic inflammatory dermatoses—primarily psoriasis and moderate-to-severe atopic dermatitis—and metabolic syndrome, including its key components: obesity, insulin resistance, dyslipidemia, hypertension, and type 2 diabetes mellitus. Population-based studies and meta-analyses consistently demonstrate a higher prevalence of metabolic syndrome and related metabolic abnormalities in patients with chronic inflammatory skin disease, with stronger associations observed in more severe disease phenotypes. Mechanistic data support these observations, highlighting shared inflammatory pathways, cytokine signaling, adipokine imbalance, and immunometabolic interactions as common underlying processes. The findings discussed in this review reinforce the concept of systemic inflammation as a unifying framework linking skin and metabolic disease. Recognizing chronic inflammatory dermatoses as markers of increased metabolic risk has important implications for clinical practice, preventive strategies, and medical education. An integrated, multidisciplinary approach may facilitate earlier identification of cardiometabolic risk and improve long-term outcomes, particularly in regions experiencing a rising burden of metabolic disease, such as Latin America.